Wearable perspiration sensor for continuous inflammation tracking in inflammatory bowel disease
Inflammatory Bowel Diseases · 01.11.2026 · 32 (11) · 2095-2102
DOI: 10.1093/ibd/izag173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 28.08.2026. Verfasst von Sarah Shahub und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bioengineering Department, University of Texas at Dallas, Richardson, TX, United States. Hauptthemen laut MEDLINE: C-Reactive Protein, Leukocyte L1 Antigen Complex, Crohn Disease, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Crohn's and Colitis Foundation, EnLiSense LLC, Crohn’s and Colitis Foundation.
Abstract (Originalsprache)
Background
Wearable sensors present an opportunity to monitor inflammation via noninvasive media such as perspiration, which may be sampled continuously to track biomarkers in inflammatory bowel disease (IBD). Here we demonstrate the use of a perspiration sensor for C-reactive protein (CRP) and calprotectin and their clinical significance.
Methods
Thirty-three patients with IBD were enrolled in a cross-sectional study of CRP and calprotectin perspiration expression compared to expression in serum and stool, respectively. Perspiration on-body measurements were obtained every minute using a wearable sensor worn for 40-130 minutes during standard of care assessment. Synchronously collected serum levels were measured, as was fecal calprotectin from a subcohort.
Results
Principal component analysis of demographic data identified age, disease activity, and diagnosis as the major contributors to variance in the dataset. When endoscopic scores were incorporated into the PCA, both disease activity and endoscopy score were identified as contributing most strongly to the primary variance. In perspiration and serum, median CRP was observed to be elevated in patients with Crohn’s disease (CD) compared to ulcerative colitis, while median calprotectin was elevated in UC compared to CD. Median calprotectin across perspiration, serum, and stool was observed to be elevated in IBD of the colon over isolated ileal IBD. Furthermore, median perspiration and serum CRP were elevated in patients under 40 years of age compared to those 40 and older, whereas median perspiration, serum, and fecal calprotectin were elevated in patients 40 and older compared to the younger cohort.
Conclusions
We report the use of a noninvasive perspiration sensor for tracking inflammatory markers in patients with IBD and demonstrate consistency of perspiration CRP and calprotectin measurements with corresponding serum and stool measurements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioengineering Department, University of Texas at Dallas, Richardson, TX, United States.
- Medicine Inflammatory Bowel Disease Center, University of Chicago, Chicago, IL, United States.
- Enlisense LLC, Allen, TX 75013, United States.
ORCID-Profile: David T Rubin, Shalini Prasad
Förderung
- Crohn's and Colitis Foundation
- EnLiSense LLC
- Crohn’s and Colitis Foundation
Zitieren
APA
Shahub, S., Lin, K. C., Choi, N. K., Garcia, N. M., Muthukumar, S., Rubin, D. T., & Prasad, S. (2026). Wearable perspiration sensor for continuous inflammation tracking in inflammatory bowel disease. Inflammatory Bowel Diseases, 32(11), 2095-2102. https://doi.org/10.1093/ibd/izag173
Vancouver
Shahub S, Lin KC, Choi NK, Garcia NM, Muthukumar S, Rubin DT, et al. Wearable perspiration sensor for continuous inflammation tracking in inflammatory bowel disease. Inflammatory Bowel Diseases. 2026;32(11):2095-2102. doi:10.1093/ibd/izag173
BibTeX
@article{Shahub2026,
author = {Shahub, Sarah and Lin, Kai-Chun and Choi, Natalie K and Garcia, Nicole M and Muthukumar, Sriram and Rubin, David T and Prasad, Shalini},
title = {Wearable perspiration sensor for continuous inflammation tracking in inflammatory bowel disease},
journal = {Inflammatory Bowel Diseases},
year = {2026},
volume = {32},
number = {11},
pages = {2095--2102},
doi = {10.1093/ibd/izag173}
}
EUVIMED